Minimally invasive options for gastrointestinal stromal tumors of the stomach.


Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
03 2021
Historique:
received: 06 08 2019
accepted: 14 03 2020
pubmed: 30 3 2020
medline: 21 7 2021
entrez: 30 3 2020
Statut: ppublish

Résumé

Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors, most commonly arising in the stomach. Surgical resection remains the mainstay of cure, and can often be accomplished laparoscopically. Tumor size and location guide selection of appropriate resection technique. A retrospective review of all patients undergoing surgery at a single academic center between 2000 and 2018. Comparisons and descriptive statistics performed using student's t test and χ 77 patients underwent resection for gastric GIST, 53 (68%) laparoscopic. Patients undergoing open operations had significantly larger tumors (4 cm vs 7 cm, p < 0.001). Operative time was not significantly different between the two groups (117 min vs 104 min, p = 0.26). Median length of stay was significantly shorter for laparoscopic resection, and postoperative complication rate was lower. A review of the operative notes revealed four types of resection: non-anatomic stapled wedge resection, resection of a full-thickness "disk" of stomach around the tumor with primary closure, formal partial gastrectomy with reconstruction, and laparoscopic transgastric (endoluminal) resection. Non-anatomic resection (wedge or disk) is most feasible for tumors on the greater curve or gastric body, far enough from the pylorus and gastroesophageal junction to avoid narrowing inflow or outflow. A partial gastrectomy may be required for large tumors or those encroaching on the esophagus or pylorus. For small intraluminal tumors, a laparoscopic transgastric approach is ideal. This review of the technical details of each type of resection can aid in selecting the ideal approach for difficult tumors.

Sections du résumé

BACKGROUND
Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors, most commonly arising in the stomach. Surgical resection remains the mainstay of cure, and can often be accomplished laparoscopically. Tumor size and location guide selection of appropriate resection technique.
METHODS
A retrospective review of all patients undergoing surgery at a single academic center between 2000 and 2018. Comparisons and descriptive statistics performed using student's t test and χ
RESULTS
77 patients underwent resection for gastric GIST, 53 (68%) laparoscopic. Patients undergoing open operations had significantly larger tumors (4 cm vs 7 cm, p < 0.001). Operative time was not significantly different between the two groups (117 min vs 104 min, p = 0.26). Median length of stay was significantly shorter for laparoscopic resection, and postoperative complication rate was lower. A review of the operative notes revealed four types of resection: non-anatomic stapled wedge resection, resection of a full-thickness "disk" of stomach around the tumor with primary closure, formal partial gastrectomy with reconstruction, and laparoscopic transgastric (endoluminal) resection.
CONCLUSION
Non-anatomic resection (wedge or disk) is most feasible for tumors on the greater curve or gastric body, far enough from the pylorus and gastroesophageal junction to avoid narrowing inflow or outflow. A partial gastrectomy may be required for large tumors or those encroaching on the esophagus or pylorus. For small intraluminal tumors, a laparoscopic transgastric approach is ideal. This review of the technical details of each type of resection can aid in selecting the ideal approach for difficult tumors.

Identifiants

pubmed: 32221752
doi: 10.1007/s00464-020-07510-x
pii: 10.1007/s00464-020-07510-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1324-1330

Références

Mazur MT, Clark HB (1983) Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 7:507–519
doi: 10.1097/00000478-198309000-00001
Eisenberg BL, Trent JC (2011) Adjuvant and neoadjuvant imatinib therapy: current role in the management of gastrointestinal stromal tumors. Int J Cancer 129:2533–2542
doi: 10.1002/ijc.26234
Pierie JP, Choudry U, Muzikansky A, Yeap BY, Souba WW, Ott MJ (2001) The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 136:383–389
doi: 10.1001/archsurg.136.4.383
DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231:51–58
doi: 10.1097/00000658-200001000-00008
Lukaszczyk JJ, Preletz RJ Jr (1992) Laparoscopic resection of benign stromal tumor of the stomach. J Laparoendosc Surg 2:331–334
doi: 10.1089/lps.1992.2.331
Kim JJ, Lim JY, Nguyen SQ (2017) Laparoscopic resection of gastrointestinal stromal tumors: does laparoscopic surgery provide an adequate oncologic resection? World J Gastrointest Endosc 9:448–455
doi: 10.4253/wjge.v9.i9.448
Piessen G, Lefevre JH, Cabau M et al (2015) Laparoscopic versus open surgery for gastric gastrointestinal stromal tumors: what is the impact on postoperative outcome and oncologic results? Ann Surg 262:831–839
doi: 10.1097/SLA.0000000000001488
MacArthur KM, Baumann BC, Nicholl MB (2017) Laparoscopic versus open resection for gastrointestinal stromal tumors (GISTs). J Gastrointest Cancer 48:20–24
doi: 10.1007/s12029-016-9861-1
Hu J, Or BH, Hu K, Wang ML (2016) Comparison of the post-operative outcomes and survival of laparoscopic versus open resections for gastric gastrointestinal stromal tumors: a multi-center prospective cohort study. Int J Surg 33:65–71
doi: 10.1016/j.ijsu.2016.07.064
Miettinen M, Sobin LH, Lasota J (2005) Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29:52–68
doi: 10.1097/01.pas.0000146010.92933.de

Auteurs

Laura Mazer (L)

Department of Surgery, University of Michigan, 1500 E. Medical Center Dr., Ann Arbor, MI, 48109, USA. lmazer@med.umich.edu.

Patrick Worth (P)

Department of Surgery, Stanford University School of Medicine, Palo Alto, CA, USA.

Brendan Visser (B)

Department of Surgery, Stanford University School of Medicine, Palo Alto, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH